Another Down Month for GWDN Index; Clinical Data Drops 24 Percent in June | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Only nine of the 34 stocks that comprise the GenomeWeb Daily News Index gained ground during another tough month for the stock market.

Three of the companies included in the Index — Clinical Data, Compugen, and Nanosphere — were hit hardest, with all of them falling more than 20 percent for June. Clinical Data had the largest decline, closing the month down 24 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.